CorMedix Inc.
CRMD
$5.92
-$0.18-2.95%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.93M | -46.15M | -53.12M | -50.24M | -46.34M |
| Total Depreciation and Amortization | 309.80K | 194.80K | 135.20K | 75.70K | 70.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.41M | 6.30M | 6.07M | 5.86M | 5.63M |
| Change in Net Operating Assets | -39.41M | -16.09M | -3.88M | -1.02M | 2.23M |
| Cash from Operations | -50.61M | -55.75M | -50.79M | -45.33M | -38.41M |
| Capital Expenditure | -115.80K | -401.80K | -402.20K | -373.80K | -327.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.35M | 22.53M | 15.63M | 6.94M | -16.73M |
| Cash from Investing | 21.23M | 22.13M | 15.22M | 6.57M | -17.06M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 26.61M | 15.74M | 44.56M | 48.91M | 56.12M |
| Repurchase of Common Stock | -289.60K | -236.60K | -236.60K | -295.50K | -198.40K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 26.32M | 15.50M | 44.33M | 48.62M | 55.92M |
| Foreign Exchange rate Adjustments | -1.70K | 1.90K | -600.00 | -300.00 | 2.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.07M | -18.11M | 8.76M | 9.86M | 448.40K |
